Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001584830 | SCV001813745 | pathogenic | not provided | 2023-06-12 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25525159, 10713884, 30730578) |
Labcorp Genetics |
RCV002569114 | SCV003440365 | pathogenic | Exostoses, multiple, type 2 | 2022-04-01 | criteria provided, single submitter | clinical testing | Disruption of this splice site has been observed in individual(s) with hereditary multiple exostoses (PMID: 10713884). ClinVar contains an entry for this variant (Variation ID: 1211965). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. This sequence change affects a donor splice site in intron 2 of the EXT2 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in EXT2 are known to be pathogenic (PMID: 10679937, 19810120). This variant is not present in population databases (gnomAD no frequency). |